Diabetes and Mortality

Diabetes Public Health: From Data to Policy

Volumn , Issue , 2011, Pages

  Saydah, Sharon H ^a   Eberhardt, Mark S ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

Author keywords

Causes of death; Death rates; Diabetes; Mortality rates

Indexed keywords

EID: 84920528475     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195317060.003.0013     Document Type: Chapter

References (85)

1. Adler AI et al. (2000). Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal 321, 412-9.
2. Agency for Healthcare Research and Quality (2008). Available at. Accessed April 21, 2008.
3. American College of Endocrinology (2004). Position Statement on Inpatient Diabetes and Metabolic Control Endocrine Practice 10(1), 77-82.
4. American Diabetes Association. (2003) Treatment of hypertension in adults with diabetes. Diabetes Care 26, S80-2.
5. American Diabetes Association. (2008). Standards of Medical Care in Diabetes-2008. Diabetes Care 30(S1), S41.
6. Anderson RJ et al. (2001). The prevalence of comorbid depression in adults with diabetes:a meta-analysis. Diabetes Care 24, 1069-78.
7. Anderson RN et al. (2001) Comparability of cause of death between ICD-9 and ICD-10:preliminary estimates. National Vital Statistics Report 49(2), 1-32.
8. Andresen EM et al (1993). Underreporting of diabetes on death certificates, King County, Washington. American Journal of Public Health 83, 1021-4.
9. Balkau B et al. (1999) Is there a glycemic threshold for mortality risk? Diabetes Care 22, 696-9.
10. Barrett-Connor E, Wingard DL. (1983). Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. American Journal of Epidemiology 118, 489-96.
11. Barrett-Connor EL et al. (1991). Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265, 627-31.
12. Billings JS (1896). Report on Vital and Social Statistics at the 11th Census, 1890, Part I Analysis and Rate Tables. Available at. Accessed August 1, 2007.
13. Booth GL et al. (2006). Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 29, 32-7.
14. Brun E et al. (2000). Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 23, 1119-23.
15. Bruno G et al. (1999) Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (noninsulin-dependent) diabetes mellitus. Diabetologia 42, 297-301.
16. Centers for Disease Control (CDC) (1991). Sensitivity of death certificate data for monitoring diabetes mortality-Diabetic Eye Disease Follow-up Study, 1985-1990. MMWR Morbidity and Mortality Weekly Report 40, 739-41.
17. Centers for Disease Control and Prevention (CDC) (2007). Racial disparities in diabetes mortality among persons aged 1-19 years, United States 1979-2004. MMWR Morbidity and Mortality Weekly Report 56(45), 1184-7.
18. Centers for Disease Control and Prevention National Center for Health Statistics (2000). Leading Causes of Death, 1900-1998. Available at. Accessed September 5, 2007.
19. Centers for Disease Control and Prevention National Center for Health Statistics. (2007) International Classification of Diseases, Tenth Revision. Centers for Disease Control and Prevention, National Center for Health Statistics. Available at. Accessed August 31, 2007.
20. Chaturvedi N et al. (1998). Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall Study and the WHO Multinational Study of Vascular Disease in Diabetes. British Medical Journal 316, 100-5.
21. Cheng WS et al. (2008). Sensitivity and specificity of death certificates for diabetes. Diabetes Care 31, 279-84.
22. Cowie CC et al. (2006). Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29, 1263-8.
23. DECODE Study Group (1999). Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative Analysis Of Diagnostic Criteria in Europe. Lancet 354, 617-21.
24. de Vegt F et al. (1999). Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42, 926-31.
25. DiLiberti JH, Lorenz RA (2001). Long-term trends in childhood diabetes mortality: 1968-1998. Diabetes Care 24, 1348-52.
26. Fiscella K (2003). Assessing Health Care Quality for Minority and Other Disparity Populations. U.S. Department of Health and Human Services, Agency for Healthcare Research and Quality; Report AHRQ Publication No. 03-0047-EF. Available at. Accessed April 16, 2010.
27. Franco OH et al. (2007). Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Archives of Internal Medicine 167, 1145-51.
28. Fuller JH et al. (2001) Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl. 2), S54-64.
29. Gavin K (2006). University unveils plan to encourage use of medications to control diabetes. University of Michigan News Service.5-2-2006. (Accessed 8-17-2007) Available at Accessed August 17, 2007.
30. Geiss L et al. (1995) Mortality in Non-Insulin Dependent Diabetes. In Harris MI et al., eds. Diabetes in America. 2nd ed., pp 233-55. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468, Bethesda, MD
31. Gerstein HC. (1999) Is glucose a continuous risk factor for cardiovascular mortality? Diabetes Care 22, 659-60.
32. Gorina Y, Lentzer H. (2008). Multiple causes of death in old age. Aging Trends. Report No. 9 Hyattsville, MD: National Center for Health Statistics (accessed September 29, 2008) Available at. Accessed April 16, 2010
33. Gregg EW et al. (2007). Mortality trends in men and women with diabetes, 1971 to 2000. Annals of Internal Medicine 147, 149-55.
34. Gu K et al. (1999). Diabetes and decline in heart disease mortality in US adults. JAMA 281, 1291-7.
35. Healthy People 2010 Progression Review: Focus Area 5: Diabetes (2006). U.S. Department of Health and Human Services. Available at. Accessed August 17, 2007.
36. Heron M, Anderson RN (2006). Diabetes reporting on death certificates in Kentucky, 2002-2003. 2006 National Center for Health Statistics Data Users Conference. Available at:. Accessed September 29, 2008.
37. Hoyert DL et al. (2000). Effect of changes in death certificate format on cause-specific mortality trends, United States, 1979-92. In Death certification and mortality statistics: An international perspective. Report 64. Office for National Statistics; London.
38. HR 3373: Catalyst to Better Diabetes Care Act of 2007, Congressional Record-House (2007). August 3, 2007. Available at. Accessed April 16, 2010.
39. Huxley R et al. (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. British Medical Journal 332, 73-8.
40. Katon WJ et al. (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28, 2668-72.
41. Kronmal RA, et al. (2006). Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001. PLoS Medicine 3(10), e400.
42. Kung HC et al. (2008) Deaths: final data for 2005. National Vital Statistics Report 56(10), 1-120.
43. Lee ET et al. (1998) All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. American Journal of Epidemiology 147, 995-1008.
44. Levitan EB et al. (2004). Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Archives of Internal Medicine 164, 2147-55.
45. Lotufo PA et al. (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Archives of Internal Medicine 161, 242-7.
46. Lu TH et al. (2006) Certifying diabetes-related cause-of-death: a comparison of inappropriate certification statements in Sweden, Taiwan and the USA. Diabetologia 49, 2878-81.
47. Medicare Preventive Services: Diabetes Screening, Supplies and Self-Management Training (2008). Available at. Accessed April 20, 2008.
48. Miettinen H et al (1996). Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care 19, 1445-8.
49. Minino AM et al. (2007). Deaths: final data for 2004. National Vital Statistics Report 55(19), 1-120.
50. Morrish NJ et al. (2001). Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl. 2), S14-21.
51. Mortality Statistics (1909). Mortality Statistics 1907. Eighth Annual Report. Available at. Accessed April 16, 2010.
52. Mulnier HE et al. (2006). Mortality in people with type 2 diabetes in the UK. Diabetic Medicine 23, 516-21.
53. Murray CJ et al. (2008). Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care 31, 451-8.
54. Narayan KM et al. (2003). Lifetime risk for diabetes mellitus in the United States. JAMA 290, 1884-90.
55. Narayan KM et al. (2006). Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 29, 2114-6.
56. Nathan DM et al. (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine 353, 2643-53.
57. National Center for Health Statistics (1947). Vital Statistics in the United States, 1900-1940. Table 14. Available at. Accessed August 1, 2007.
58. National Center for Health Statistics (1992). Advance Report of Final Mortality Statistics, 1989. Monthly Vital Statistics National Center for Health Statistics; Vol. 40, No. 8, Suppl. 2. p 1-52. Available at. Accessed April 16, 2010.
59. National Center for Health Statistics (2007). Health, United States, 2007 with Chartbook on Trends in Health of Americans. Available at. Accessed August 1, 2008.
60. National Center for Health Statistics. (2008). DATA2010. Available at. Accessed July 14, 2008.
61. National Conference of State Legislatures (2007). State Laws Mandating Diabetes Health Coverage. National Conference of State Legislatures. Available at. Accessed August 17, 2007.
62. National Diabetes Mellitus Research and Education Act (1974). § Public Law 93-354.
63. National Heart, Lung, and Blood Institute, National Institutes of Health, National High Blood Pressure Education Program (2004). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, Publication No. 04-5230.
64. National Institute of Health National Institute for Diabetes and Digestive and Kidney Diseases (2007). National Diabetes Education Program. Available at. Accessed September 29, 2008.
65. Nilsson PM et al. (1998). Low educational status is a risk factor for mortality among diabetic people. Diabetic Medicine 15, 213-9.
66. Office of Disease Prevention and Health Promotion, U.S. Department of Health and Human Services (2006). Summary Report, Healthy People 2010 Progress Review, Diabetes. Available at. Accessed August 17, 2007.
67. Pambianco G et al. (2006). The 30-year natural history of type 1 diabetes complications:the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55, 1463-9.
68. Portuese E, Orchard T (1995). Mortality in insulin-dependent diabetes. In Harris MI et al., eds. Diabetes in America, 2nd ed., pp 221-32. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, NIH Publication No. 95-1468.
69. Qiao Q et al. (2003). Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during followup. Diabetes Care 26, 2910-4.
70. Rijkelijkhuizen JM et al. (2007). High risk of cardiovascular mortality in individuals with impaired fasting glucose is explained by conversion to diabetes: the Hoorn study. Diabetes Care 30, 332-6.
71. Rosen AB et al. (2005). Cost-effectiveness of full medicare coverage of angiotensinconverting enzyme inhibitors for beneficiaries with diabetes. Annals of Internal Medicine 143, 89-99.
72. Rosenberg HM et al. (1999). Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital and Health Statistics Series 2(128), 1-13.
73. Saaddine JB, et al. (2006). Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Annals of Internal Medicine 144, 465-74.
74. Saydah SH et al. (2001). Subclinical states of glucose intolerance and risk of death in the U.S. Diabetes Care 24, 447-53.
75. Saydah SH et al. (2002). Age and the burden of death attributable to diabetes in the United States. American Journal of Epidemiology 156, 714-9.
76. Saydah SH et al. (2004). Review of the performance of methods to identify diabetes cases among vital statistics, administrative, and survey data. Annals of Epidemiology 14, 507-16.
77. Schrier RW et al (2007). Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nature Clinical Practice Nephrology 3, 428-38.
78. State-Based Diabetes Prevention & Control Programs. Centers for Disease Control and Prevention, Division of Diabetes Translation (2007). Available at. Accessed September 5, 2007.
79. Statehealthfacts.org (2007). Key Health and Healthcare Indicators by Race/ethnicity and State. The Henry J. Kaiser Family Foundation. Available at. Accessed August 17, 2007.
80. Stern MP (1998). Invited commentary: cardiovascular mortality in American Indians:paradox explained? American Journal of Epidemiology 147, 1009-10.
81. Stevens RJ, Holman R (2004). Comparative study of prognostic value for coronary disease risk between the U.K. Prospective diabetes study and Framingham models:response to Protopsaltis et al. Diabetes Care 27, 1843-4.
82. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837-53.
83. Vaccaro O et al. (1998) Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT). International Journal of Epidemiology 27, 636-41.
84. Vijan S, Hayward RA (2004). Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Annals of Internal Medicine 140, 650-8.
85. Wilder RP (2003). Education and mortality in type 2 diabetes. Diabetes Care 26, 1650.